IBSA invests in women’s health with the launch of Hyaluxelle®
Technology, science and culture are fundamental aspects of IBSA’s commitment to offering an effective and pragmatic approach to the needs of patients; placing the patient at the centre means first and foremost celebrating their individuality, and recognising their unique and specific nature.
In this sense, the world of women’s health has always been a privileged driver of investment for the company, which has, over the years, focused increasing attention on solutions dedicated to improving not only the health, but also the quality of life of female patients.
Although some progress has been made, differences still remain in levels of attention and investment which, on a global scale, see women’s health penalised. A recent study by McKinsey & Company maintains that women experience an average of 9 more years of poor health than men, above all in the working age population.
IBSA has recently launched Hyaluxelle®, a solution for adult women that helps patients suffering from genitourinary syndrome of menopause (GSM), of which one of the symptoms is vulvovaginal atrophy (VVA).
This is a condition that affects up to 90% of post-menopausal women, and to which IBSA responds in three ways:
- Scientific research and innovative biofermentation treatments
Hyaluxelle® can be seen as the result of a combination of research, innovation and commitment to improving the lives of patients, as it is composed of a solution of hyaluronic acid (HA) of high molecular weight (H-HA) and low molecular weight (L-HA) obtained through biofermentation and without the use of chemical modification techniques, resulting in excellent product tolerance and elevated biocompatibility.
- Innovation and patented technology
IBSA research is combined with innovative technology, thanks to a specific and patented treatment, NAHYCO® Hybrid Technology, which results in unique rheological properties that allow for higher concentrations of HA to be delivered without any increase in solution viscosity.
- Quality of life
Lastly, IBSA has also focused on rendering products simple to use, with pre-filled syringes that guarantee the utmost comfort.
Hyaluxelle® is the result of an overall commitment to developing solutions for women’s health that are effective, created to offer a pragmatic response to their needs while also designed to minimise therapy related stress, significantly improving quality of life for the patient.
Find out more in the virtual room dedicated to Hyaluxelle®
Discover Hyaluxelle®